ASTH vs SGRY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Sell and SGRY is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green whileSGRY’s FA Score has 0 green FA rating(s).
- ASTH’s FA Score: 0 green, 5 red.
- SGRY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 4 TA indicator(s) are bullish while SGRY’s TA Score has 4 bullish TA indicator(s).
- ASTH’s TA Score: 4 bullish, 6 bearish.
- SGRY’s TA Score: 4 bullish, 6 bearish.
Price Growth
ASTH (@Medical/Nursing Services) experienced а -13.10% price change this week, while SGRY (@Medical/Nursing Services) price change was -24.41% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.01%. For the same industry, the average monthly price growth was -3.13%, and the average quarterly price growth was +1650.83%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 20, 2025.
SGRY is expected to report earnings on Mar 03, 2025.
Industries' Descriptions
@Medical/Nursing Services (-4.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ASTH | SGRY | ASTH / SGRY | |
| Capitalization | 1.88B | 3.66B | 52% |
| EBITDA | 124M | 446M | 28% |
| Gain YTD | 6.554 | -28.259 | -23% |
| P/E Ratio | 32.55 | N/A | - |
| Revenue | 1.39B | 2.74B | 51% |
| Total Cash | 296M | 196M | 151% |
| Total Debt | 321M | 3.06B | 10% |
ASTH | SGRY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 70 | 66 | |
SMR RATING 1..100 | 64 | 87 | |
PRICE GROWTH RATING 1..100 | 64 | 86 | |
P/E GROWTH RATING 1..100 | 86 | 58 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ASTH's Valuation (68) in the null industry is in the same range as SGRY (100) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.
SGRY's Profit vs Risk Rating (66) in the Hospital Or Nursing Management industry is in the same range as ASTH (70) in the null industry. This means that SGRY’s stock grew similarly to ASTH’s over the last 12 months.
ASTH's SMR Rating (64) in the null industry is in the same range as SGRY (87) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.
ASTH's Price Growth Rating (64) in the null industry is in the same range as SGRY (86) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.
SGRY's P/E Growth Rating (58) in the Hospital Or Nursing Management industry is in the same range as ASTH (86) in the null industry. This means that SGRY’s stock grew similarly to ASTH’s over the last 12 months.
| ASTH | SGRY | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 81% | 3 days ago 75% |
| Stochastic ODDS (%) | 3 days ago 86% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 66% | 3 days ago 75% |
| MACD ODDS (%) | 3 days ago 77% | 3 days ago 73% |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 76% |
| TrendMonth ODDS (%) | 3 days ago 75% | 3 days ago 78% |
| Advances ODDS (%) | 12 days ago 79% | 13 days ago 83% |
| Declines ODDS (%) | 3 days ago 71% | 3 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 83% | 3 days ago 75% |
| Aroon ODDS (%) | 3 days ago 81% | 3 days ago 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AEIMX | 9.49 | -0.01 | -0.11% |
| American Century Equity Income G | |||
| GMOEX | 24.58 | -0.07 | -0.28% |
| GMO Emerging Markets III | |||
| MNDFX | 9.22 | -0.03 | -0.32% |
| Manning & Napier Disciplined Value I | |||
| AMKIX | 11.42 | -0.06 | -0.52% |
| American Century Emerging Markets I | |||
| DIVGX | 16.39 | -0.18 | -1.09% |
| Guardian Capital Dividend Growth Instl | |||
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AMN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AMN could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | -2.60% | ||
| AMN - ASTH | 53% Loosely correlated | -0.71% | ||
| CCRN - ASTH | 46% Loosely correlated | -2.00% | ||
| USPH - ASTH | 42% Loosely correlated | +0.29% | ||
| SGRY - ASTH | 38% Loosely correlated | -7.35% | ||
| AVAH - ASTH | 38% Loosely correlated | +1.09% | ||
More | ||||
SGRY and
Correlation & Price change
A.I.dvisor indicates that over the last year, SGRY has been loosely correlated with THC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRY jumps, then THC could also see price increases.
| Ticker / NAME | Correlation To SGRY | 1D Price Change % | ||
|---|---|---|---|---|
| SGRY | 100% | -7.35% | ||
| THC - SGRY | 51% Loosely correlated | -4.49% | ||
| HCA - SGRY | 49% Loosely correlated | -0.74% | ||
| UHS - SGRY | 46% Loosely correlated | +0.34% | ||
| SEM - SGRY | 45% Loosely correlated | +0.56% | ||
| CYH - SGRY | 43% Loosely correlated | -3.76% | ||
More | ||||